Company: WELNF
Filing Date: 2025-11-17
Form Type: DEF 14A
Source: 0001104659-25-113213
Chunk: 61

Company: Integrated Wellness Acquisition Corp
Filing Date: 2025-11-17
Form: DEF 14A
Chunk 61
---
 15, 2025 to complete an initial business combination. The Company currently believes that there
may not be sufficient time before December 15, 2025 to complete the Business Combination. The purpose of the Extension Amendment is to
allow the Company more time to complete the Business Combination. Accordingly, the Company believes that in order to be able to consummate
the Business Combination, the Company will need to obtain the Extension. Therefore, the Board has determined that it is in the best interests
of the Company’s shareholders to extend the date by which the Company has to consummate a Business Combination to the Extended Date.
Notwithstanding the foregoing, the Company will cancel the Meeting and will not implement the Extension if it is able to complete the
Business Combination prior to the Meeting.

We intend to hold another
shareholder meeting prior to the Extended Date in order to seek shareholder approval of the Business Combination. If the M&A Amendments
are approved and implemented, the Board will have the flexibility to liquidate the Trust Account to redeem all public shares on a specified
date following the approval and implementation of the M&A Amendments at any time before or after December 15, 2025, and prior
to the end of the Extension Period.

<div align='center'>37</div>

If the M&A Amendments are Approved

If the M&A Amendments
are approved and implemented, the Company will file the M&A in the form of Annex A hereto to extend the time it has to complete
a Business Combination until the Extended Date. The Company will then continue to attempt to consummate a Business Combination until the
Extended Date, or until such earlier date as determined by the Board in its sole discretion. The Company will remain a reporting company
under the Securities and Exchange Act of 1934 (the “Exchange Act”) and its Class A Ordinary
Shares and Public Warrants will remain publicly traded during this time.

You are not being asked to vote on the Business Combination at the Meeting. The vote by the Company shareholders on the Business Combination will occur at the separate Business Combination Meeting of the Company shareholders and the solicitation of proxies from the Company shareholders in connection with such separate Business Combination Meeting, and the related right of the Company shareholders to redeem in connection with the Business Combination (which is a separate right to redeem in addition to the right to redeem in connection with the M&A Amendment Proposals), is the subject of a separate proxy statement/prospectus. If you want to ensure your Public Shares are redeemed in the event the M